IVAV
NERV icon

Index Venture Associates V’s Minerva Neurosciences NERV Stock Holding History

Index Venture Associates V’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-94,742
Closed -$5.56M – 2
2020
Q1 		$4.56M Hold
94,742
– – 2% 2
2019
Q4 		$5.39M Hold
94,742
– – 1.8% 2
2019
Q3 		$5.87M Hold
94,742
– – 2.34% 2
2019
Q2 		$4.27M Sell
94,742
-17,252
-15% -$863K 0.72% 2
2019
Q1 		$7.04M Hold
111,994
– – 0.91% 2
2018
Q4 		$6.04M Sell
111,994
-375
-0.3% -$27.4K 1.15% 3
2018
Q3 		$11.3M Sell
112,369
-1,611
-1% -$121K 1.39% 3
2018
Q2 		$7.52M Hold
113,980
– – 25.48% 2
2018
Q1 		$5.7M Hold
113,980
– – 18.91% 2
2017
Q4 		$5.52M Buy
+113,980
New +$5.65M 8% 3

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Index Venture Associates V's NERV Position: Q2 2020 in Review

Index Venture Associates V sold out of Minerva Neurosciences (NERV) in Q2 2020, closing a stake of 94,742 shares — an estimated $5.56M sold.

Index Venture Associates V first reported a position in NERV in Q4 2017 and held it in 10 quarters. The position peaked at $11.3M in Q3 2018. 80 funds tracked by Wall St. Rank hold NERV as of Q2 2020.

  • Index Venture Associates V reported no remaining Minerva Neurosciences position as of Q2 2020 after selling out during the quarter.
  • Index Venture Associates V sold 94,742 Minerva Neurosciences shares in Q2 2020, an estimated $5.56M.
  • Index Venture Associates V first reported a position in Minerva Neurosciences in Q4 2017 and held it in 10 quarters.
  • Index Venture Associates V's Minerva Neurosciences position peaked at $11.3M in Q3 2018.
  • 80 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2020.

Based on Index Venture Associates V's 13F filing for Q2 2020, filed 12 Aug 2020.